WHO ICTRP trial
The effect of melatonin on patients with hemorrhagic stroke
IRCT2016100530164N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2016100530164N1 |
|---|---|
| Public title | The effect of melatonin on patients with hemorrhagic stroke |
| Scientific title | The benefit of Melatonin on damage associated molecular pattern following hemorrhagic strokepatients under mechanical ventilation |
| Primary sponsor | Vice chancellor for research, Tehran university of medical sience |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | nontraumatic intracranial haemorrhage. Intracranial haemorrhage (nontraumatic), unspecified;Intracranial haemorrhage (nontraumatic), unspecified |
| Interventions | Intervention 1: Melatonin tablet 30 mg every night for 5 days. Intervention 2: There is no intervention in control group.;Treatment - Drugs;Melatonin tablet 30 mg every night for 5 days;There is no intervention in control group |
| Registration date | Mar 4, 2017 |
| Target size | 40 |
| Secondary IDs | 162.9 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: